JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company') |
|
Legal Entity Identifier: 549300D8SPJFHBDGXS57 |
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 January 2022 |
|
Growth Portfolio * |
|
Nestle |
5.2% |
Roche Holdings |
4.1% |
JPMorgan European Discovery Trust plc |
3.9% |
ASML |
3.8% |
LVMH |
3.7% |
Novo Nordisk |
3.1% |
TotalEnergies |
2.5% |
Novartis |
2.1% |
Siemens |
2.1% |
BNP Paribas |
1.9% |
Total |
32.3% |
Income Portfolio * |
|
Nestle |
5.4% |
Roche Holdings |
4.3% |
ASML |
4.0% |
LVMH |
3.9% |
Novo Nordisk |
3.3% |
TotalEnergies |
2.6% |
Novartis |
2.3% |
Siemens |
2.2% |
BNP Paribas |
2.0% |
L'oreal |
2.0% |
Total |
32.1% |
* Based on invested portfolio |
|
Name of contact and telephone number for queries: |
|
Paul Ainger 0044 207 742 6524 |
|
Name of authorised company official responsible for making this notification: |
|
Paul Winship 0044 207 742 9815 - Company Secretary |
|
Date: 14 February 2022 |
|
|
|